We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AQS Aequus Pharmaceuticals Inc

0.00 (0.00%)
24 Feb 2024 - Closed
Delayed by 15 minutes

Aequus Pharmaceuticals Financial Summary

The current AQS market cap is 1.99M. The company's latest EPS is CAD -0.0242 and P/E is -0.41.

Year End 31 December 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 1.41M1.63M2.59M2.72M1.38M
Operating Income -2.81M-2.32M-604k-1.06M-2.16M
Net Income -2.8M-3.11M-1.05M-1.81M-3.21M
Year End 31 December 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 2M1.67M3.13M4.35M1.69M
Total Liabilities 314k2.55M2.56M2.56M3.07M
Total Equity 1.68M-877k574k1.79M-1.38M

Cash Flow

Year End 31 December 2022 20182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -2.57M-1.63M-805k-1.17M-1.95M
Investing -11k-3k-12k-508k N/A
Financing 1.79M1.75M2.05M2.4M-189k
Market Cap 1.99M
Price to Earnings Ratio -0.41
Price to Sales Ratio 0.96
Price to Cash Ratio 5.26
Price to Book Ratio -0.96
Dividend Yield -

Share Statistics

Shares Outstanding 132.63M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (25%)

Company Info

Company Name Aequus Pharmaceuticals Inc
Address suite 2600, 595 burrard street
vancouver, british columbia V7X 1L3
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |